The c.–292C>T promoter polymorphism increases reticulocyte-type 15-lipoxygenase-1 activity and could be atheroprotective

MLA

Mathias Bayer, et al. “The c.–292C>T Promoter Polymorphism Increases Reticulocyte-Type 15-Lipoxygenase-1 Activity and Could Be Atheroprotective.” Clinical Chemical Laboratory Medicine, vol. 45, Jan. 2007. EBSCOhost, https://doi.org/10.1515/cclm.2007.103.

APA

Mathias Bayer, Jörg Muntwyler, Martin Hersberger, Armin Mosandl, & Jonas Wittwer. (2007). The c.–292C>T promoter polymorphism increases reticulocyte-type 15-lipoxygenase-1 activity and could be atheroprotective. Clinical Chemical Laboratory Medicine, 45. https://doi.org/10.1515/cclm.2007.103

Chicago

Mathias Bayer, Jörg Muntwyler, Martin Hersberger, Armin Mosandl, and Jonas Wittwer. 2007. “The c.–292C>T Promoter Polymorphism Increases Reticulocyte-Type 15-Lipoxygenase-1 Activity and Could Be Atheroprotective.” Clinical Chemical Laboratory Medicine 45 (January). doi:10.1515/cclm.2007.103.